Fig. 6.
Fig. 6. IL-2, IL-15, and EPO activate Raf1-1 in CTLL-EPO-R cells. CTLL-EPO-R cells were depleted of cytokine for 8 hours in RPMI-1 mg/mL bovine serum albumin (BSA). Stimulations were conducted with no added cytokine (lane 1), 50 U of human EPO per mL (lane 2), 50 U of murine IL-2 per milliliter (lane 3), 100 ng of murine IL-4 per milliliter (lane 4), or 100 ng of simian IL-15 per milliliter (lane 5). After cell lysis, an immunoprecipitation was performed using an anti-Raf1 antibody, followed by an in vitro kinase reaction using MEK1 as an exogenous substrate. Samples were resolved by SDS-PAGE, transferred to nitrocellulose, and then exposed to film.

IL-2, IL-15, and EPO activate Raf1-1 in CTLL-EPO-R cells. CTLL-EPO-R cells were depleted of cytokine for 8 hours in RPMI-1 mg/mL bovine serum albumin (BSA). Stimulations were conducted with no added cytokine (lane 1), 50 U of human EPO per mL (lane 2), 50 U of murine IL-2 per milliliter (lane 3), 100 ng of murine IL-4 per milliliter (lane 4), or 100 ng of simian IL-15 per milliliter (lane 5). After cell lysis, an immunoprecipitation was performed using an anti-Raf1 antibody, followed by an in vitro kinase reaction using MEK1 as an exogenous substrate. Samples were resolved by SDS-PAGE, transferred to nitrocellulose, and then exposed to film.

Close Modal

or Create an Account

Close Modal
Close Modal